Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Revenue | 1.37M | 1.39M | 1.40M | 1.06M | 712.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37M | 1.39M | 1.40M | 1.06M | 712.60K |
| Cost of Revenue | 1.84M | 2.06M | 2.58M | 2.61M | 3.05M |
| Gross Profit | -471.90K | -668.30K | -1.18M | -1.55M | -2.34M |
| SG&A Expenses | 1.93M | 2.06M | 2.28M | 2.33M | 2.31M |
| Depreciation & Amortization | 8.80K | 9.00K | 9.30K | 9.60K | 9.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.79M | 4.14M | 4.87M | 4.94M | 5.36M |
| Operating Income | -2.41M | -2.74M | -3.47M | -3.89M | -4.65M |
| Income Before Tax | -2.34M | -2.66M | -3.36M | -3.77M | -4.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.34 | -2.66 | -3.36 | -3.77 | -4.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.34M | -2.66M | -3.36M | -3.77M | -4.59M |
| EBIT | -2.41M | -2.74M | -3.47M | -3.89M | -4.65M |
| EBITDA | -2.41M | -2.73M | -3.46M | -3.88M | -4.64M |
| EPS Basic | -0.04 | -0.04 | -0.06 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | -0.04 | -0.04 | -0.06 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 267.12M | 245.02M | 222.56M | 218.81M | 216.18M |
| Average Diluted Shares Outstanding | 267.12M | 245.02M | 222.56M | 218.81M | 216.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |